Disease Mechanism
ReviveMed discovers detailed molecular pathways associated with a disease.
Novel Therapeutic Targets
We can reveal novel therapeutic targets by leveraging data from metabolites.
Drug Reprofiling
Using metabolomics, we identify new therapeutic effects for existing drugs or drugs in development.
Drug mechanisms of action
Our solutions can reveal underlying molecular mechnisms through which a drug produces its pharmacological effect.
Biomarker Discovery
We discover mechanistic-based biomarker signature associated with a disease or a drug treatment from biofluid metabolomic data.
Overcoming the Difficulties of Using Metabolomics
Our technology was developed at MIT, and published in Nature Methods.
Using our proprietary database and machine-learning algorithm, we reduce the need for costly and time-consuming experiments to identify a large set of metabolites, and integrate these data with other large-scale molecular datasets such as genomics and proteomics.